NC 100182
Alternative Names: HelispinLatest Information Update: 08 Sep 2006
At a glance
- Originator GE Healthcare
- Class Contrast media
- Mechanism of Action Magnetic resonance imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 08 Sep 2006 Discontinued - Phase-II for Chronic obstructive pulmonary disease (diagnosis) in USA (Inhalation)
- 16 Apr 2004 Amersham has merged with GE Medical Systems to form GE Healthcare
- 15 Mar 2002 Phase-II clinical trials in Chronic obstructive pulmonary disease (diagnosis) in USA (Inhalation)